DalCor Pharmaceuticals website screenshot

DalCor Pharmaceuticals

DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Montreal, Quebec, with offices in Zug, Switzerland, Leatherhead in the United Kingdom, and Sarasota, Florida. It is developing dalcetrapib, positioned as the first pharmacogenetic precision medicine in cardiovascular disease, targeted specifically at patients carrying the AA genotype at the rs1967309 variant of the ADCY9 gene — a genotype present in up to 20% of the general population and in more than 40% of populations of African ancestry. DalCor holds the worldwide exclusive license to develop, manufacture and commercialise dalcetrapib together with rights to the companion genetic marker. The compound is being evaluated in Dal-GenE-2 (DAL-302), a Phase 3 double-blind randomized placebo-controlled cardiovascular outcomes confirmatory trial in 2,000 post-acute-coronary-syndrome patients with the ADCY9 AA genotype, coordinated by the Montreal Health Innovations Coordinating Centre and following the dal-GenE (DAL-301) trial, which showed a 21% relative risk reduction in fatal and non-fatal myocardial infarction across 6,149 patients in 34 countries. DalCor runs no developer program and publishes no product API; the only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind dalcorpharma.com, which serves the bilingual English/French corporate site.

DalCor Pharmaceuticals publishes 7 APIs on the APIs.io network, including Categories API, Comments API, Discovery API, and 4 more. Tagged areas include Company, Pharmaceuticals, Biotechnology, Cardiovascular, and Precision Medicine.

DalCor Pharmaceuticals’ developer surface includes support, authentication, and 23 more developer resources.

19.0/100 emerging ▬ flat Agent 25/100 agent aware Full breakdown ↓
scored 2026-09-03 · rubric v0.18.2
AccessSelf serve
7 APIs
CompanyPharmaceuticalsBiotechnologyCardiovascularPrecision MedicinePharmacogenomicsClinical TrialsLife Sciencescontent-api

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-03 · rubric v0.18.2
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/dalcor-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →
Something on this page wrong about DalCor Pharmaceuticals? Report it → Free, always, and read by a human — corrections are worked from the queue daily. Agents can file the same report through the report_correction tool on the apis.io MCP.

APIs 7

Individual APIs this provider publishes, each with its own machine-readable definition.

DalCor Pharmaceuticals Comments API

Comments on posts (collection is empty on this site)

DalCor Pharmaceuticals Discovery API

Site index, namespace route index, content types, taxonomies and statuses

DalCor Pharmaceuticals Media API

Media library items (logos, poster PDFs/JPEGs, trial imagery)

DalCor Pharmaceuticals Pages API

Corporate, science and clinical-trial pages

DalCor Pharmaceuticals Posts API

DalCor press releases and corporate news

DalCor Pharmaceuticals Search API

Cross-content search

Scroll for all 7

Open Collections 8

Open, tool-agnostic API collections (OpenAPI-derived and Bruno).

API Collection

OPEN COLLECTION

Scroll for all 8

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Dalcor Pharmaceuticals Authentication

http · 1 scheme

SECURITY

Dalcor Pharmaceuticals Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 5

Pagination, idempotency, versioning, errors, and events

Access & Security 2

Authentication, authorization, and security posture

Operate 3

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 6

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: dalcor-pharmaceuticals
name: DalCor Pharmaceuticals
description: DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Montreal,
  Quebec, with offices in Zug, Switzerland, Leatherhead in the United Kingdom, and Sarasota, Florida. It is developing dalcetrapib,
  positioned as the first pharmacogenetic precision medicine in cardiovascular disease, targeted specifically at patients
  carrying the AA genotype at the rs1967309 variant of the ADCY9 gene — a genotype present in up to 20% of the general population
  and in more than 40% of populations of African ancestry. DalCor holds the worldwide exclusive license to develop, manufacture
  and commercialise dalcetrapib together with rights to the companion genetic marker. The compound is being evaluated in Dal-GenE-2
  (DAL-302), a Phase 3 double-blind randomized placebo-controlled cardiovascular outcomes confirmatory trial in 2,000 post-acute-coronary-syndrome
  patients with the ADCY9 AA genotype, coordinated by the Montreal Health Innovations Coordinating Centre and following the
  dal-GenE (DAL-301) trial, which showed a 21% relative risk reduction in fatal and non-fatal myocardial infarction across
  6,149 patients in 34 countries. DalCor runs no developer program and publishes no product API; the only machine-readable
  surface it exposes is the anonymously readable WordPress REST content API behind dalcorpharma.com, which serves the bilingual
  English/French corporate site.
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: true
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - openapi
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: self-serve
  trial: false
  try_now: false
  public: false
  label: Self-serve signup
  confidence: low
  source:
  - authentication
  - security
  generated: '2026-09-02'
  method: derived
image: https://dalcorpharma.com/kicmeefo/2023/09/dalcor-logo.png
url: https://raw.githubusercontent.com/api-evangelist/dalcor-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Cardiovascular
- Precision Medicine
- Pharmacogenomics
- Clinical Trials
- Life Sciences
- content-api
tags_raw:
- Company
- pharmaceuticals
- biotechnology
- cardiovascular
- precision-medicine
- pharmacogenomics
- clinical-trials
- life-sciences
- content-api
apis:
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-categories-api
  name: DalCor Pharmaceuticals Categories API
  description: Post categories
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Categories
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-categories-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-comments-api
  name: DalCor Pharmaceuticals Comments API
  description: Comments on posts (collection is empty on this site)
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Comments
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-comments-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-discovery-api
  name: DalCor Pharmaceuticals Discovery API
  description: Site index, namespace route index, content types, taxonomies and statuses
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Discovery
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-discovery-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-media-api
  name: DalCor Pharmaceuticals Media API
  description: Media library items (logos, poster PDFs/JPEGs, trial imagery)
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Media
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-media-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-pages-api
  name: DalCor Pharmaceuticals Pages API
  description: Corporate, science and clinical-trial pages
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Pages
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-pages-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-posts-api
  name: DalCor Pharmaceuticals Posts API
  description: DalCor press releases and corporate news
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Posts
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-posts-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-search-api
  name: DalCor Pharmaceuticals Search API
  description: Cross-content search
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Search
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-search-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/dalcor-pharmaceuticals-content-overlay.yaml
- type: Website
  url: https://dalcorpharma.com/
- type: About
  url: https://dalcorpharma.com/about/
- type: Management
  url: https://dalcorpharma.com/about/management/
- type: BoardOfDirectors
  url: https://dalcorpharma.com/about/board-of-directors/
- type: Partners
  url: https://dalcorpharma.com/about/partners/
- type: Science
  url: https://dalcorpharma.com/science/cardiovascular-diseases/
- type: Publications
  url: https://dalcorpharma.com/science/publications/
- type: PressReleases
  url: https://dalcorpharma.com/press-releases/
- type: BlogRSS
  url: https://dalcorpharma.com/feed/
- type: Contact
  url: https://dalcorpharma.com/contact-us/
- type: Support
  url: https://dalcorpharma.com/contact-us/
- type: PrivacyPolicy
  url: https://dalcorpharma.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/dalcor-pharmaceuticals/
- type: SecondaryMarket
  url: https://forgeglobal.com/dalcor-pharmaceuticals_stock/
- type: Authentication
  url: authentication/dalcor-pharmaceuticals-authentication.yml
- type: Conventions
  url: conventions/dalcor-pharmaceuticals-conventions.yml
- type: Conformance
  url: conformance/dalcor-pharmaceuticals-conformance.yml
- type: ErrorCatalog
  url: errors/dalcor-pharmaceuticals-problem-types.yml
- type: Lifecycle
  url: lifecycle/dalcor-pharmaceuticals-lifecycle.yml
- type: DataModel
  url: data-model/dalcor-pharmaceuticals-data-model.yml
- type: WellKnown
  url: well-known/dalcor-pharmaceuticals-well-known.yml
- type: DomainSecurity
  url: security/dalcor-pharmaceuticals-domain-security.yml
- type: LLMsTxt
  url: llms/dalcor-pharmaceuticals-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-04'
  status: enriched
  artifacts_added: 15
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/dalcor-pharmaceuticals"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/dalcor-pharmaceuticals/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/dalcor-pharmaceuticals/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.